Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07023094 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated July 11, 2025 (before its estimated May 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jul 1, 2025 to Jun 16, 2025
    • Interventions: 0.2% ropivacaine (Drug), 0.2% ropivacaine (Drug) to Ropivacaine 0.2% for L-ESPB (Drug), Ropivacaine 0.2% for LFCB (Drug), Ropivacaine 0.2% for PENG Block (Drug), Ropivacaine 0.2% for S-ESPB…
    • Study site revised
    v2
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This randomized controlled trial (RCT) compares the analgesic effectiveness of two regional anesthesia techniques-Pericapsular Nerve Group (PENG) block combined with Lateral Femoral Cutaneous Nerve Block (LFCB) versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB)-in pediatric patients undergoing hip surgery.
Trial Details
NCT Number NCT07023094
Lead Sponsor Poznan University of Medical Sciences
Conditions
(from sponsor)		 Hip Disease, Hip Dysplasia, Hip Arthropathy
Related terms Hip Dislocation
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov